What Researchers Did
Researchers investigated whether a bioengineered human amniotic membrane-derived scaffold loaded with SDF-1α (SHAMS) combined with hyperbaric oxygen (HBO) could improve diabetic wound healing in rats.
What They Found
The HBO+SHAMS-D group showed the highest improvements in wound closure, new dermis and epidermis volume, and numerical density of basal cells, fibroblasts, and blood vessels compared to other groups. This group also exhibited the highest number of proliferating cells, collagen deposition, and better biomechanical properties of healed wounds, alongside significant upregulation of Vegf, bFgf, and Tgf-β genes.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A primary limitation of this study is that its findings are based on animal models (rats) and may not directly translate to human physiology or clinical outcomes.